Uveal Neoplasms [clinicaltrials_resource:c19f590e98a9a2439f6927d4f5fbec4f]
condition [clinicaltrials_vocabulary:condition]
Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer [clinicaltrials:NCT00002947]Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer [clinicaltrials:NCT00003022]Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma [clinicaltrials:NCT00003339]Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma [clinicaltrials:NCT00003802]Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma [clinicaltrials:NCT00005815]Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma [clinicaltrials:NCT00005841]Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye [clinicaltrials:NCT00020475]Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery [clinicaltrials:NCT00025181]Temozolomide and Interferon Alfa in Treating Patients With Stage III or Stage IV Melanoma [clinicaltrials:NCT00027742]Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma [clinicaltrials:NCT00031733]Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma [clinicaltrials:NCT00032045]Vaccine Therapy in Treating Patients With Melanoma of the Eye [clinicaltrials:NCT00036816]Monoclonal Antibody Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00058279]Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma [clinicaltrials:NCT00072345]clinicaltrials:NCT00084656clinicaltrials:NCT00085189Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery [clinicaltrials:NCT00089206]clinicaltrials:NCT00089219FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma [clinicaltrials:NCT00104884]Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma [clinicaltrials:NCT00110123]clinicaltrials:NCT00121225PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma [clinicaltrials:NCT00238329]clinicaltrials:NCT00243061Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00288041]clinicaltrials:NCT00313508clinicaltrials:NCT00324727clinicaltrials:NCT00329641Vaccine Therapy in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00334776]clinicaltrials:NCT00398073Validation of a Molecular Prognostic Test for Eye Melanoma [clinicaltrials:NCT00406120]clinicaltrials:NCT00445965clinicaltrials:NCT00450255Tilting of Radioactive Plaques After Initial Accurate Placement for Treatment of Uveal Melanoma [clinicaltrials:NCT00459849]clinicaltrials:NCT00471133clinicaltrials:NCT00471471clinicaltrials:NCT00482911Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma [clinicaltrials:NCT00489944]Safety and Efficacy of Marqibo in Metastatic Malignant Uveal Melanoma [clinicaltrials:NCT00506142]clinicaltrials:NCT00596362clinicaltrials:NCT00661622
condition browse [clinicaltrials_vocabulary:condition-browse]
Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer [clinicaltrials:NCT00002947]Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer [clinicaltrials:NCT00003022]Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma [clinicaltrials:NCT00003339]Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma [clinicaltrials:NCT00003802]Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma [clinicaltrials:NCT00005815]Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma [clinicaltrials:NCT00005841]Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye [clinicaltrials:NCT00020475]Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery [clinicaltrials:NCT00025181]Temozolomide and Interferon Alfa in Treating Patients With Stage III or Stage IV Melanoma [clinicaltrials:NCT00027742]Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma [clinicaltrials:NCT00031733]Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma [clinicaltrials:NCT00032045]Vaccine Therapy in Treating Patients With Melanoma of the Eye [clinicaltrials:NCT00036816]Monoclonal Antibody Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00058279]Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma [clinicaltrials:NCT00072345]clinicaltrials:NCT00084656clinicaltrials:NCT00085189Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery [clinicaltrials:NCT00089206]clinicaltrials:NCT00089219FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma [clinicaltrials:NCT00104884]Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma [clinicaltrials:NCT00110123]clinicaltrials:NCT00121225PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma [clinicaltrials:NCT00238329]clinicaltrials:NCT00243061Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00288041]clinicaltrials:NCT00313508clinicaltrials:NCT00324727clinicaltrials:NCT00329641Vaccine Therapy in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00334776]clinicaltrials:NCT00398073Validation of a Molecular Prognostic Test for Eye Melanoma [clinicaltrials:NCT00406120]clinicaltrials:NCT00445965clinicaltrials:NCT00450255Tilting of Radioactive Plaques After Initial Accurate Placement for Treatment of Uveal Melanoma [clinicaltrials:NCT00459849]clinicaltrials:NCT00471133clinicaltrials:NCT00471471clinicaltrials:NCT00482911Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma [clinicaltrials:NCT00489944]Safety and Efficacy of Marqibo in Metastatic Malignant Uveal Melanoma [clinicaltrials:NCT00506142]clinicaltrials:NCT00596362clinicaltrials:NCT00661622
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Uveal Neoplasms [clinicaltrials_resource:c19f590e98a9a2439f6927d4f5fbec4f]
Bio2RDF identifier
c19f590e98a9a2439f6927d4f5fbec4f
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:c19f590e98a9a2439f6927d4f5fbec4f
identifier
clinicaltrials_resource:c19f590e98a9a2439f6927d4f5fbec4f
title
Uveal Neoplasms
@en
type
label
Uveal Neoplasms [clinicaltrials_resource:c19f590e98a9a2439f6927d4f5fbec4f]
@en
Uveal Neoplasms